ARCHIVES

Part One Of A Two-Part Interview With NCI Director Harold Varmus

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Northwestern To Test Method To Detect Colon Cancer

February 25, 2005

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

March 7, 2014

FDA Orders More Changes In ESA Label,

August 8, 2008

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007